AutoImmune Incorporated

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical productsfor the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. At the start of 1999 the Company was conducting clinical trials for the following products: Colloral(R), for the treatment of rheumatoid arthritis, and AI 502, for the treatment of chronic transplant rejection. A third product, AI 401, for the treatment of Type 1 diabetes, is in Phase II clinical trials supported by Eli Lilly and Company ("Lilly") and the National Institutes of Health ("NIH"). The Company believes, based on preclinical and clinical data, that its proprietary approach to therapy can induce tissue-specific immunosuppression without toxicity or significant side effects. Additional clinical and commercial advantages of this approach include the ability to administer products orally (the preferred method of treating chronic diseases) and the potential for application to a variety of inflammatory diseases and conditions.

Contact Details: 1199 Madia Street Pasadena CA 91103 United States of America Tel: 626 792 1235 Fax: 626 792 1236 Email: WWW: www.autoimmuneinc.com/

Loading...

Recent Publications by AutoImmune Incorporated:
B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. Autoreactive B cells are regulated in the BM during development through...	19th July, 2008	Department of Microbiology, Columbia University Medical Center, New York,	J Clin Invest. 2008 Jul 17;. DOI Direct Link
Whither TSH Receptor Blocking Antibodies in the Treatment of Graves' Disease? Autoreactive B cells are regulated in the BM during development through...	18th July, 2008	Autoimmune Disease Unit, Cedars-Sinai Research Institute and UCLA School	Thyroid. 2008 Jul;18(7):695-6. DOI Direct Link
Primary Sjogren Syndrome in Spain: Clinical and Immunologic Expression in 1010 Patients. We conducted the current study to characterize the clinical presentation...	16th July, 2008	From Laboratory of Autoimmune Diseases "Josep Font," Department of	Medicine (Baltimore). 2008 Jul;87(4):210-219. DOI Direct Link
A Man With Sicca Symptoms and Bilateral Parotid Enlargement. We conducted the current study to characterize the clinical presentation...	16th July, 2008	Section of Rheumatology and Autoimmune Diseases, Hospital JB Iturraspe,	South Med J. 2008 Jul 9;. DOI Direct Link
Interleukin-10 -592C/A, -819C/T, and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes patients. Background: The IL-10 polymorphic variants -1082G/A, -819C/T, and -592C/A...	12th July, 2008	Research unit of Biology and Genetics of Cancer and Haematological and	Clin Endocrinol (Oxf). 2008 Jun 27;. DOI Direct Link
→View more AutoImmune Incorporated research publications.

BioNews Results for AutoImmune Incorporated:
Boehringer Ingelheim Licenses Drug Targets from Autoimmune Collaboration with BioFocus DPI	CombiChemnet:  Jul 19 2008 12:37AM Matching: autoimmune
Boehringer Ingelheim Licenses Drug Targets from Autoimmune Collaboration with BioFocus DPI	GenomicsProteomics.com:  Jul 18 2008 2:23PM Matching: autoimmune
Latest News, Developments and Drug Pipelines for Central Nervous System Multiple Sclerosis	Pharma Live:  Jul 18 2008 3:30AM Matching: autoimmune
Boehringer Ingelheim Licenses Drug Targets from Autoimmune Collaboration with Galapagos	Pharma Live:  Jul 18 2008 3:29AM Matching: autoimmune
First AbD Serotec Generated HuCAL Antibodies Distributed as Part of Clinical Diagnostic Kits for Autoimmune Di	Pharma Live:  Jul 17 2008 6:14PM Matching: autoimmune
Promote your company here: BioNewsCast - Press Release Distribution	→View more AutoImmune Incorporated news.

AutoImmune Incorporated Patents:
US Patent No.	Title
6703361	Method of treating or preventing Type 1 diabetes by oral administration of insulin
5807993	HP-8 autoantigen
5788968	Methods and compositions for suppressing allograft rejection in mammals
5783188	Method of treating rheumatoid arthritis with type collagen peptide fragments containing repeating sequences
5763396	Method of treating or preventing type 1 diabetes by oral administration of insulin
→View more AutoImmune Incorporated patents.

AutoImmune Incorporated (AIMM) Financial information Links from Barchart
AIMM Quote from from Barchart.com
AIMM Chart from from Barchart.com
AIMM Profile from from Barchart.com
AIMM Opinion from from Barchart.com
→View more AutoImmune Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 221 individuals from AutoImmune Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 420 times since April 2007, the link to the organisation's website has been followed 75 times

Recent Search Terms used to find this page: autoimmune diseases | autoimmunity drug discovery meeting 2008 | t | treatment hospital infection April 2008 | autoimmune contact home company about search | autoimmune pharmaceuticals AI 401 | autoimmune incorporated | ai-401 nih | .

Search for more companies in Pasadena

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AutoImmune Incorporated